T&R Biofab Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

1.71

EPS

—

Div Yield, %

—

Shrs. gr., 5y

22.30%

Rev. gr., 5y

31.70%

Revenues

26.97b

+453.32%

Net income

-34.84b

L+353.76%

CFO

-7.47b

L-36.37%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

T&R Biofab Co., Ltd. is dedicated to advancing medical technology through the development of innovative devices designed for tissue regeneration and transplantation procedures. Their work primarily serves the fields of orthopedics, plastic surgery, and dentistry. The company's product line encompasses custom patient implants, such as craniomaxillofacial and dental meshes. They also provide cutting-edge bioinks for 3D bioprinting and cell culture, alongside solutions for stem cell research and delivery, and specialized coatings for laboratory scaffolds and culture dishes. This enterprise was established in 2013 and operates from its base in Siheung-si, South Korea.

URL

http://www.tnrbiofab.com

IPO date

Nov 28, 2018

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT